Calpain Inhibitor I, ALLN: Technical Guidance & Protocols
2026-05-29
Calpain Inhibitor I, ALLN offers selective inhibition of calpain and cathepsin proteases for apoptosis and ischemia-reperfusion injury models, supporting workflows that require precise control of proteolytic events. It is not suitable for diagnostic, medical, or aqueous-only applications, and requires careful handling to maintain stability and potency.
BFH772 (VEGFR2 inhibitor): Technical Usage and Protocol Guid
2026-05-28
BFH772 is a potent, selective VEGFR2 inhibitor developed for precise suppression of VEGFR2-mediated angiogenesis in tumor model research. It is unsuitable for workflows requiring water solubility or broad-spectrum kinase inhibition, making it best reserved for experiments targeting VEGFR2-specific pathways.
Naftifine HCl: Mechanistic Insights and Research-Grade Antif
2026-05-28
Explore Naftifine HCl, a potent allylamine antifungal agent, through a mechanistic and methodological lens. This article delivers deep scientific analysis, links research-grade properties to assay design, and contextualizes Naftifine HCl within the landscape of antifungal and cellular signaling research.
Practical Use of Hoechst 33342/PI Double Staining Kit (K2237
2026-05-27
The Hoechst 33342/PI Double Staining Kit enables rapid, fluorescence-based differentiation of viable, apoptotic, and necrotic cells by targeting nuclear chromatin and membrane integrity. This tool is well-suited for basic research workflows requiring clear identification of cell death modes via microscopy. It is not suitable for diagnostic or clinical use.
Phosbind Biotin LC: Protocol Guidance for Phosphorylated Pro
2026-05-27
Phosbind Biotin LC is designed for sequence-independent detection of phosphorylated proteins on PVDF membranes in Western Blot workflows. It enables researchers to analyze phosphorylation without dependence on phospho-specific antibodies. This phosphate-binding reagent should not be used in aqueous-only protocols or where long-term storage of working solutions is required.
Modulating the NOX2/ROS/Mitochondria/NLRP3 Axis in Ulcerativ
2026-05-26
Xu Chunfu’s Modified Xianglian Pill (XXLP) demonstrates a novel mechanism for treating ulcerative colitis by regulating the NOX2/ROS/mitochondria/NLRP3 signaling pathway and reshaping the gut microbiota. This study provides robust evidence for the molecular and microbiological basis of XXLP’s efficacy, opening new directions for targeted therapy in inflammatory bowel disease.
BCECF-AM: Precision Intracellular pH Measurement in Live Cel
2026-05-26
BCECF-AM sets the benchmark for live-cell ratiometric pH assays across plant, animal, and microbial systems. Its cell permeability and robust signal make it indispensable for dissecting dynamic protein secretion and endomembrane pH regulation.
AZD2461 in Functional Drug Response Profiling: Precision Too
2026-05-26
Explore how the novel PARP inhibitor AZD2461 empowers advanced breast cancer research by enabling nuanced functional drug response profiling and overcoming Pgp-mediated resistance. This article offers a unique, protocol-focused perspective grounded in recent methodological innovations.
Angiotensin II Drives Radioresistance in NPC via HIF-1α-HILP
2026-05-25
This study uncovers how local angiotensin II (Ang II) promotes radioresistance in nasopharyngeal carcinoma (NPC) by suppressing ferroptosis through the HIF-1α-HILPDA axis. The findings identify novel molecular targets and suggest that dual inhibition of Ang II signaling and induction of ferroptosis could enhance radiotherapy outcomes for NPC.
IGF2BP3–FZD1/7 Axis Drives Stemness and Carboplatin Resistan
2026-05-24
A recent study uncovers how IGF2BP3, an m6A reader, stabilizes FZD1/7 transcripts and activates β-catenin signaling, enhancing cancer stemness and carboplatin resistance in triple-negative breast cancer. This work highlights a promising therapeutic target for improving chemoresponse and reducing recurrence in TNBC.
Applied Uses of Recombinant Human IL-15 in Immune Cell Assay
2026-05-23
Recombinant Human IL-15 (E.coli, Tag Free, Lyophilized) from APExBIO empowers robust T and NK cell proliferation with unmatched purity and activity. This article delivers advanced workflows, troubleshooting strategies, and practical insights for optimizing immune response modulation in translational research.
Z-VEID-FMK: Unveiling Caspase-6 Inhibition in Inflammatory P
2026-05-22
Explore the pivotal role of Z-VEID-FMK as a caspase-6 inhibitor in neuroinflammation and pain research. Dive into innovative findings that distinguish this compound’s use in apoptosis assays and neuronal studies.
C-Terminal Mutation in VZV gE Enhances mRNA Vaccine Immunity
2026-05-22
This study investigates how specific carboxyl-terminal mutations in varicella-zoster virus glycoprotein E (gE) influence the efficacy of mRNA vaccines. The findings support that targeted mutations can improve both humoral and cellular immune responses, providing a rational basis for next-generation varicella and zoster vaccine design.
Transmission Dynamics of Carbapenemase Genes in CREC in Chin
2026-05-21
This study provides a detailed molecular epidemiology of carbapenem-resistant Enterobacter cloacae (CREC) in Guangdong, China (2022–2024), focusing on carbapenemase-encoding gene (CEG) prevalence, localization, and transmission. The findings reveal extensive plasmid-mediated dissemination of blaNDM-1 and multidrug resistance, informing future strategies for antibiotic resistance surveillance and experimental modeling.
Procainamide Hydrochloride in Cardiac & Epigenetic Assays
2026-05-21
Procainamide Hydrochloride, a trusted APExBIO reagent, enables high-fidelity cardiac sodium channel and DNA methylation studies by combining robust electrophysiological and epigenetic activity. This article delivers actionable workflows, troubleshooting insights, and bridges recent innovations in tumor immunology with experimental design for advanced translational research.
459 records 17/31 page Previous Next First page 上5页 1617181920 下5页 Last page